TY  - JOUR
T1  - HYperactivity and medication-reply
AU  - VARGA JR
Y1  - 1979/12/01
N1  - 10.1001/archpedi.1979.02130120079020
JO  - American Journal of Diseases of Children
SP  - 1288
EP  - 1288
VL  - 133
IS  - 12
N2  - In Reply.—I share many of Dr Smith's concerns regarding the use of stimulant medication in children with attentional difficulties. I do believe that he overstates the potential for harm with regard to the long-term cardiovascular effects. The overwhelming majority of follow-up studies do not indicate that this is a major problem area. The work by Sprague and Slater1 suggests that our end points for titrating medication effect may need to differentiate between learning and behavioral phenomena. This is a development that I strongly encourage and have emphasized in the article.It is not my intention or desire to suggest that medication should be the mainstay of therapy. It is helpful for carefully selected children as part of a more comprehensive program that uses educational and behavioral intervention strategies. Rather than reserving its use for situations where "all else fails" as recommended by Dr Smith, I would suggest a
SN  - 0002-922X
M3  - doi: 10.1001/archpedi.1979.02130120079020
UR  - http://dx.doi.org/10.1001/archpedi.1979.02130120079020
ER  -